Pulmonary Hypertension Archives - The Cardiology Advisor

Pulmonary Vasculature

Pulmonary Hypertension Ups Kidney Graft Dysfunction Risk

By

Natasha Persaud

May 13, 2022

Pulmonary hypertension is common among patients with chronic kidney disease or end-stage kidney disease.

Pulmonary Vasculature

Can Echocardiography Assess Pulmonary Hypertension Defined by Lower mPAP Cutoff?

By

Sheila Jacobs

March 10, 2022

How would the redefinition of pulmonary hypertension, proposed at the 2018 World Symposium on PH, affect echocardiographic prediction of PH?

Heart Failure

Hemodynamic Variables in Pulmonary Hypertension Due to Left Heart Disease

By

Colby Stong

March 3, 2022

A prospective registry study evaluated the prognostic value of multiple pulmonary hemodynamic variables for risk prediction in PH-LHD.

Heart Failure

RV Dysfunction Index Predicts Outcomes in Patients With HFrEF, PH Postdischarge

By

Cardiology Advisor Contributing Writer

January 14, 2022

Researchers examined the effects of RV dysfunction on the clinical outcomes of patients hospitalized with heart failure with and without pulmonary hypertension.

Hypertension

Low Forced Expiratory Volume in Chronic Thromboembolic Pulmonary Hypertension

By

Bryant Moeller

January 12, 2022

Is there a significant relationship between obstructive impairment and the low forced expiratory volumes frequently seen in patients with CTEPH?

Hypertension

Linking Severity, Prognosis of Chronic Thromboembolic PH With HRR1 Post Exercise

By

Sheila Jacobs

December 28, 2021

Is there a link between the severity and prognosis of chronic thromboembolic pulmonary hypertension and attenuated heart rate recovery at 1 minute?

Obstructive Sleep Apnea, tablet, stethoscope

Hypertension

Risk Factors for Pulmonary Hypertension Combined With Obstructive Sleep Apnea

By

Virginia A. Schad, PharmD, RPh

December 17, 2021

A recent Chinese study sought to identify clinical predictors of pulmonary hypertension combined with obstructive sleep apnea.

Pulmonary Vasculature

Inhaled Treprostinil Approval Decision Delayed Over Inspection Issue

By

Diana Ernst, RPh

October 21, 2021

Tyvaso DPI is an investigational drug-device combination therapy that consists of a dry powder formulation of treprostinil and a small, portable, dry powder inhaler.